stockrowGoodRx Holdings, Inc. (GDRX) vs Omnicell, Inc. (OMCL)
- GoodRx Holdings, Inc. GDRX 3.50 +0.29%
- Omnicell, Inc. OMCL 37.35 −1.79%
GoodRx Holdings, Inc. and Omnicell, Inc. are both Health Information Services companies. Omnicell, Inc. is the larger, with a market value of $1.7B against $1.2B — 1.5× the size. Omnicell, Inc. trades at the lower P/E: 39.0× against 65.7×. Omnicell, Inc. grew revenue faster over the last twelve months: 5.62% against −1.83%. Omnicell, Inc. has the higher net margin (3.59% vs 2.07%) and the lower return on invested capital (3.45% vs 5.59%). Across the 22 metrics below, GoodRx Holdings, Inc. leads on 11 and Omnicell, Inc. on 11.
Valuation
Profitability
| Metric | GDRX | OMCL | Health Information Services median |
|---|---|---|---|
| Gross margin | 90.83% | 45.14% | 59.61% |
| Operating margin | 9.54% | 5.20% | (10.54%) |
| Net margin | 2.07% | 3.59% | (16.14%) |
| Free cash flow margin | 16.77% | 10.67% | 0.00% |
| Return on equity | 2.52% | 0.00% | (3.15%) |
| Return on assets | 0.89% | 2.23% | (5.62%) |
| Return on invested capital | 5.59% | 3.45% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack